To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
107 Current news of Universität Zürich
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Drug resistance: Preventing drugs from being transported
18-Jun-2019
Certain membrane proteins specialise in transporting molecules out of cells – a problem for the efficacy of cancer medication and antibiotics. An international research team has investigated the transport mechanism of a bacterial membrane protein using an artificially produced antibody fragment. ...
Susceptibility to Disease Develops during Childhood
02-May-2019
Traumatized children and children who develop multiple allergies tend to suffer in adulthood from chronic inflammatory diseases and psychiatric disorders. Researchers at the Universities of Zurich and Lausanne have demonstrated this in a study in which they identified five classes of early ...
Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer
Using UV light, radiolabelled antibodies can be produced in just 15 minutes
24-Apr-2019
Radioactive antibodies that target cancer cells are used for medical diagnostics with PET imaging or for targeted radioimmunotherapy. Researchers from the University of Zurich have created a new method for radiolabelling antibodies using UV light. In less than 15 minutes, the proteins are ...
Precise Decoding of Breast Cancer Cells Creates New Option for Treatment
17-Apr-2019
Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over one hundred breast tumors. They've found that aggressive tumors are often dominated by a single type of tumor cell. If certain immune cells are present as ...
New Potential Approach to Treat Atopic Dermatitis
19-Mar-2019
How does the immune system respond to fungi on our skin? Researchers at the University of Zurich have demonstrated that the same immune cells that protect us against skin fungi also encourage the inflammatory symptoms of atopic dermatitis. An antibody therapy could alleviate this chronic ...
Bat Influenza Viruses Could Infect Humans
22-Feb-2019
Bats don’t only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus. These newly discovered flu viruses could potentially also attack the cells of humans and livestock, researchers at the University of Zurich have now shown. Seasonal outbreaks of the flu are ...
How Type 1 Diabetes Gradually Destroys Insulin Production
04-Feb-2019
Using the new Imaging Mass Cytometry method, Zurich researchers have investigated the pancreas of healthy organ donors and those with type 1 diabetes. The study shows that many beta cells, which normally produce insulin, are still present in the early stages of the disease, but look very ...
Potential for risky behavior is also in your genes
15-Jan-2019
As part of an international research project, a group of scientists from the University of Zurich found genetic variants associated with risk tolerance and risky behaviors. It is one of the first studies to link genetic variants with behavioral outcomes, which are relevant to social science ...
How Drugs Can Minimize the Side Effects of Chemotherapy
11-Jan-2019
Researchers at the University of Zurich have determined the three-dimensional structure of the receptor that causes nausea and vomiting as a result of cancer chemotherapy. The study explains for the first time why some drugs work particularly well in ameliorating these side effects. The results ...
From Receptor Structure to New Osteoporosis Drugs
22-Nov-2018
Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones. The receptor is now one of the main candidates for developing new drugs to treat osteoporosis. Knowing the receptor's blueprint will be ...
